JP2018520201A5 - - Google Patents

Download PDF

Info

Publication number
JP2018520201A5
JP2018520201A5 JP2018503142A JP2018503142A JP2018520201A5 JP 2018520201 A5 JP2018520201 A5 JP 2018520201A5 JP 2018503142 A JP2018503142 A JP 2018503142A JP 2018503142 A JP2018503142 A JP 2018503142A JP 2018520201 A5 JP2018520201 A5 JP 2018520201A5
Authority
JP
Japan
Prior art keywords
pyridin
pyrrolo
amino
triazin
amine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2018503142A
Other languages
English (en)
Japanese (ja)
Other versions
JP2018520201A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2016/043252 external-priority patent/WO2017015425A1/en
Publication of JP2018520201A publication Critical patent/JP2018520201A/ja
Publication of JP2018520201A5 publication Critical patent/JP2018520201A5/ja
Pending legal-status Critical Current

Links

JP2018503142A 2015-07-23 2016-07-21 Tgfベーター受容体アンタゴニスト Pending JP2018520201A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201562195854P 2015-07-23 2015-07-23
US62/195,854 2015-07-23
PCT/US2016/043252 WO2017015425A1 (en) 2015-07-23 2016-07-21 Tgf beta receptor antagonists

Publications (2)

Publication Number Publication Date
JP2018520201A JP2018520201A (ja) 2018-07-26
JP2018520201A5 true JP2018520201A5 (enExample) 2019-08-15

Family

ID=56609944

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2018503142A Pending JP2018520201A (ja) 2015-07-23 2016-07-21 Tgfベーター受容体アンタゴニスト

Country Status (6)

Country Link
US (1) US10336761B2 (enExample)
EP (1) EP3325484A1 (enExample)
JP (1) JP2018520201A (enExample)
KR (1) KR20180032611A (enExample)
CN (1) CN108026105B (enExample)
WO (1) WO2017015425A1 (enExample)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SG11201804901WA (en) 2015-12-22 2018-07-30 SHY Therapeutics LLC Compounds for the treatment of cancer and inflammatory disease
EA201992780A1 (ru) 2017-06-21 2020-06-02 ШАЙ ТЕРАПЬЮТИКС ЭлЭлСи Соединения, которые взаимодействуют с суперсемейством ras, для лечения рака, воспалительных заболеваний, ras-опатий и фиброзного заболевания
WO2019084463A1 (en) * 2017-10-26 2019-05-02 Southern Research Institute OXADIAZOLES AND THIADIAZOLES AS INHIBITORS OF TGF-BETA
US12391705B2 (en) 2018-12-19 2025-08-19 Shy Therapeutics, Llc Compounds that interact with the Ras superfamily for the treatment of cancers, inflammatory diseases, rasopathies, and fibrotic disease
AU2019417418B2 (en) 2018-12-27 2025-02-27 Nexys Therapeutics, Inc. (pyridin-2-yl)amine derivatives as ΤGFβR1 (Alk5) inhibitors for the treatment of cancer
CN111825675B (zh) * 2019-04-15 2023-08-01 武汉朗来科技发展有限公司 Rock抑制剂及其制备方法和用途
CN112694477B (zh) * 2019-10-22 2024-02-06 四川科伦博泰生物医药股份有限公司 吡唑并环类化合物,包含其的药物组合物,其制备方法及其用途
WO2021147699A1 (zh) * 2020-01-21 2021-07-29 四川科伦博泰生物医药股份有限公司 吡啶并杂环类化合物、其制备方法及用途
CN113620956B (zh) * 2020-05-06 2023-06-13 赛诺哈勃药业(成都)有限公司 转化生长因子受体拮抗剂、其制备方法和应用
IL315733A (en) * 2022-04-08 2024-11-01 SHY Therapeutics LLC Compounds that Interact with RAS Superfamily Proteins for the Treatment of Cancer, Inflammatory, Basoplastic, and Fibrotic Diseases
CN119894879A (zh) * 2022-07-14 2025-04-25 渤健马萨诸塞州股份有限公司 酪氨酸激酶2抑制剂及其用途
AU2024209823A1 (en) * 2023-01-19 2025-07-31 Skyhawk Therapeutics, Inc. Compositions useful for modulating splicing

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2285164T3 (es) * 2002-09-04 2007-11-16 Schering Corporation Pirazolopirimidinas como inhibidores de quinasas dependientes de ciclina.
WO2004065392A1 (en) * 2003-01-24 2004-08-05 Smithkline Beecham Corporation Condensed pyridines and pyrimidines and their use as alk-5 receptor ligands
US7223766B2 (en) * 2003-03-28 2007-05-29 Scios, Inc. Bi-cyclic pyrimidine inhibitors of TGFβ
ES2542647T3 (es) * 2011-03-09 2015-08-07 Merck Patent Gmbh Derivados de pirido[2,3 b]pirazina y sus usos terapéuticos
CN103450204B (zh) * 2012-05-31 2016-08-17 中国科学院上海药物研究所 吡咯[2,1-f][1,2,4]并三嗪类化合物,其制备方法及用途

Similar Documents

Publication Publication Date Title
JP2018520201A5 (enExample)
JP2022531932A5 (enExample)
US8871753B2 (en) Macrocyclic compounds and their use as kinase inhibitors
JP2022531801A5 (enExample)
RU2425826C2 (ru) СОЕДИНЕНИЯ И КОМПОЗИЦИИ В КАЧЕСТВЕ ИНГИБИТОРОВ ITPKb
US9221809B2 (en) Aminopyrimidinones as interleukin receptor-associated kinase inhibitors
US9382241B2 (en) Aminoquinazoline and pyridopyrimidine derivatives
CA2814419C (en) Cxcr4 receptor antagonists
JP2013544256A5 (enExample)
JP2011518836A5 (enExample)
RU2013124101A (ru) Гетероциклические амины и их применения
AU2018201953A1 (en) Certain amino-pyridazines, compositions thereof, and methods of their use
RU2010137300A (ru) Модуляторы бета-амилоида
RU2016133684A (ru) Бициклические азот-содержащие соединения как агонисты М1 мускариновых рецепторов
RU2009121564A (ru) Азаадамантановые производные и способы применения
JP2021535134A5 (enExample)
JP2015528022A5 (enExample)
RU2015111133A (ru) Ингибиторы тирозинкиназы брутона
EP3197884A1 (en) Aminotriazine derivatives useful as tank-binding kinase inhibitor compounds
RU2017124425A (ru) Производные 2,4-диоксо-хиназолин-6-сульфонамида в качестве ингибиторов parg
RU2009147733A (ru) Пиридилпиперидновые антагонисты рецептора орексинов
RU2016141646A (ru) Ингибиторы trka киназы, основанные на них композиции и способы
CA2422923A1 (en) Pyridine derivatives with ikb-kinase (ikk-.beta.) inhibiting activity
JP2013533300A (ja) ブルトン型チロシンキナーゼの阻害剤
JPWO2005063743A1 (ja) チアゾール誘導体